Thermo Fisher Scientific Inc (NYSE:TMO):
Thermo Fisher Scientific Declares Quarterly Dividend.
The company is now up from yesterday’s close of $178.64.
Thermo Fisher Scientific Inc announced a dividend to be paid on Monday July 17th, 2017. The dividend will be $0.150 per share for the quarter or $0.60 on an annualized basis. This dividend represents a yield of $0.34. The ex-dividend date will be on Tuesday June 13th, 2017.
Thermo Fisher Scientific Inc., launched on October 11, 1960, develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Company serves various markets, such as pharmaceutical and biotech; academic and government; industrial and applied; as well as healthcare and diagnostics. The Company serves its customers through its brands, such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services..
It is trading at $180.20 just a bit higher than $173.88, the stock’s 50 day moving average and which is just over the 200 day moving average of $158.53. The 50 day moving average went up $6.32 or +3.64% and the 200 day average went up $21.67 or +13.67%.
The company’s P/E ratio is 32.87 and the market value is 70.50B. As of the last earnings report the EPS was $5.48 and is estimated to be $9.22 for the current year with 391,219,000 shares outstanding. Next quarter’s EPS is forecasted at $2.24 and the next full year EPS is anticipated to be $10.18.
A few Wall Street analysts have weighed in on TMO of late. Cantor Fitzgerald initiated coverage on the stock with a rating of “Overweight”. On November 10 analysts at Leerink Swann issued its first research report on the stock giving it an initial rating of “Outperform”.
On September 9 the stock rating was downgraded to “Neutral” from “” in a report issued by Cleveland Research. On July 22, 2016 BTIG Research started coverage with an initial rating of “Buy” and setting a price target of $180.00.
On July 19 Barclays kept the stock rating at “Overweight” but raised the price expectation to $175.00 from $165.00. On April 29 the company was changed to a “Hold” according to a Jefferies report which is down from the previous “Buy” rating.Advertisement